The {pharmaceutical sector is rapidly exploring innovative treatment approaches for obesity , and the emergence of semaglutide 10mg injectables represents a significant change. Clinicians are cautiously assess the likely benefits and challenges associated with this higher potency version , especially in contrast with existing less potent semaglutid